0 likes | 14 Views
The importance of patients being fully informed about the benefits and drawbacks of medical devices is highlighted by the Allergan breast implant lawsuits. The significant correlation between textured implants and BIA-ALCL should prompt quick research, increased awareness, and changes in medical advice regarding alternative breast implant options.
E N D
Allergan's product portfolio holds a variety of breast implants, designed to provide a natural look. In the US market, Allergan breast implants are among the most prevalent choices.
On July 24, 2019, the Food and Drug Administration came up with a shocking report!!! It was about Breast Implant-Associated Anaplastic Large Cell Lymphoma in people who received Allergan BIOCELL® textured implants.
Textured breast implants foster an atmosphere favorable to BIA-ALCL development. The lymphoma develops as a result of immune response and chronic inflammation triggered by Allergan implants.
Federal lawsuits against the Natrelle BIOCELL Textured Breast Implants boomed after the company's recall. • The cases were combined into a New Jersey MDL class action in December 2019.
What is the status of the Allergan lawsuit? There are no bellwether trials or any sorts of global settlement in the Allergan breast implant MDL.
Allergan breast implant litigation is ongoing as an active lawsuit in the U.S. • Seek the support of an expert Allergan breast implant lawsuit lawyer to have a case evaluation.
To know More Visit https://medlegal360.com/